$58.78
0.54% yesterday
NYSE, Feb 04, 09:49 pm CET
ISIN
US26622P1075
Symbol
DOCS

Doximity Stock price

$58.75
+3.18 5.72% 1M
+32.76 126.05% 6M
+5.36 10.04% YTD
+31.50 115.60% 1Y
+13.00 28.42% 3Y
+5.75 10.85% 5Y
+5.75 10.85% 10Y
NYSE, Closing price Tue, Feb 04 2025
-0.35 0.59%
ISIN
US26622P1075
Symbol
DOCS

Key metrics

Market capitalization $10.97b
Enterprise Value $10.18b
P/E (TTM) P/E ratio 67.59
EV/FCF (TTM) EV/FCF 46.81
EV/Sales (TTM) EV/Sales 19.69
P/S ratio (TTM) P/S ratio 21.22
P/B ratio (TTM) P/B ratio 11.42
Revenue growth (TTM) Revenue growth 15.29%
Revenue (TTM) Revenue $516.85m
EBIT (operating result TTM) EBIT $202.96m
Free Cash Flow (TTM) Free Cash Flow $217.38m
Cash position $805.56m
EPS (TTM) EPS $0.87
P/E forward 70.71
P/S forward 20.31
EV/Sales forward 18.85
Short interest 4.74%
Show more

Is Doximity a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Doximity Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Doximity forecast:

6x Buy
32%
13x Hold
68%

Analyst Opinions

19 Analysts have issued a Doximity forecast:

Buy
32%
Hold
68%

Financial data from Doximity

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
517 517
15% 15%
100%
- Direct Costs 52 52
2% 2%
10%
465 465
18% 18%
90%
- Selling and Administrative Expenses 166 166
7% 7%
32%
- Research and Development Expense 86 86
2% 2%
17%
213 213
36% 36%
41%
- Depreciation and Amortization 10 10
19% 19%
2%
EBIT (Operating Income) EBIT 203 203
41% 41%
39%
Net Profit 174 174
41% 41%
34%

In millions USD.

Don't miss a Thing! We will send you all news about Doximity directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Doximity Stock News

Negative
Investors Business Daily
2 days ago
Doximity stock is in a base ahead of the company's earnings report due out Thursday after the market close. The post Doximity Holds Critical Levels In Sell-Off As Earnings Loom appeared first on Investor's Business Daily.
Neutral
Business Wire
20 days ago
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live ...
Positive
Seeking Alpha
23 days ago
Upgraded Doximity to a buy rating due to recent share price pullback, stronger engagement metrics, and deeper client relationships, creating a compelling entry point. DOCS reported 20% y/y revenue growth in 2Q25, surpassing management's guidance, with increased user adoption and higher revenue per user driving performance. The adoption of AI-driven tools and expanded Client Portal access are en...
More Doximity News

Company Profile

Doximity, Inc. operates an online platform for medical professionals. It's cloud-based software has the ability to enable the users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. The company was founded by Konstantin Guericke, Nate Gross and Jeffrey A. Tangney in April 16, 2010 and is headquartered in San Francisco, CA.

Head office United States
CEO Jeffrey Tangney
Employees 827
Founded 2010
Website www.doximity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today